Shrestha Ghosh completed her PhD from The University of Hong Kong in 2017 and joined Dana-Farber Cancer Institute (DFCI)/Harvard Medical School (HMS), Boston for postdoctoral studies in 2018. She is now an Instructor at DFCI/HMS. She is a gold medalist in her undergraduate studies and received the best doctoral thesis award in medicine faculty of HKU in 2018. Her thesis was published as a book by Elsevier in 2019. She has now co-founded a start-up to find novel therapeutics in blood-related disorders. She has published several papers in reputed journals, such as Nature Immunology, Nature Communications, Cell Metabolism, Cell Reports.